Skip to main content

Table 4 Cardiopulmonary effects of LCT and MCT/LCT in humans

From: Effects on hemodynamics and gas exchange of omega-3 fatty acid-enriched lipid emulsion in acute respiratory distress syndrome (ARDS): a prospective, randomized, double-blind, parallel group study

A (LCT)

Author

Emulsion

Infusion rate

Patients

Results

Venus[11]

20% LCT

100 g/10 h

Sepsis

Non-sepsis

↑ MPAP, ↑ Qs/Qt

Venus[12]

20% LCT

100 g/8 h

ARDS

↓ PaO2/FiO2

↑ MPAP, ↑ Qs/Qt, ↑ PVR

Hwang[8]

10% LCT

50 g/4 h

Healthy

ARDS

Pneumonia

COPD

↓ Qs/Qt, ↑ PaO2/FiO2

↑ Qs/Qt, ↓ PaO2/FiO2

No changes

No changes

Mathru[7]

20% LCT

100 g/10 h

100 g/5 h

ARDS

ARDS

↑ Qs/Qt, =MPAP

=Qs/Qt, ↑ MPAP

B (MCT/LCT)

Radermacher[13]

20% MCT/LCT

50 g/4 h

Sepsis

No changes

Fiaccadori[14]

20% MCT/LCT

3.3 mg/kg min

Heart surgery

No changes

Masclans[17]

20% LCT

20% MCT/LCT

2 mg/kg/min 12 h

2 mg/kg/min 12 h

ARDS

ARDS

↑ CO

No changes

Smyrniotis[18]

20% LCT

20% MCT/LCT

50% non-prot cal

Pancreatitis with ARDS

↑ MPAP, ↑ Qs/Qt, and ↓ PaO2/FiO2

↑ VO2, ↑ CO

Chassard[19]

20% LCT

20% MCT/LCT

3 mg/kg/min 8 h

3 mg/Kg/min 8 h

Sepsis

No changes

↑ VO2

Faucher[20]

20% LCT

20% MCT/LCT

1 ml/kg/h 6 h

1 ml/kg/h 6 h

ARDS

↑ PaO2/FiO2, ↑ DO2

Lekka[16]

20% MCT/LCT

Placebo

 

ARDS: lipids

Placebo

↓ PaO2/FiO2, ↓ Comp, ↓ PVR

  1. VO2: oxygen consumption, Comp: compliance.